
William Y. Lee
Examiner (ID: 10076, Phone: (571)270-3876 , Office: P/1629 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629, 1623 |
| Total Applications | 842 |
| Issued Applications | 341 |
| Pending Applications | 128 |
| Abandoned Applications | 407 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20083617
[patent_doc_number] => 20250213553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-03
[patent_title] => BUPRENORPHINE DOSING REGIMENS
[patent_app_type] => utility
[patent_app_number] => 19/085650
[patent_app_country] => US
[patent_app_date] => 2025-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10496
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19085650
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/085650 | BUPRENORPHINE DOSING REGIMENS | Mar 19, 2025 | Pending |
Array
(
[id] => 20083617
[patent_doc_number] => 20250213553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-03
[patent_title] => BUPRENORPHINE DOSING REGIMENS
[patent_app_type] => utility
[patent_app_number] => 19/085650
[patent_app_country] => US
[patent_app_date] => 2025-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10496
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19085650
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/085650 | BUPRENORPHINE DOSING REGIMENS | Mar 19, 2025 | Pending |
Array
(
[id] => 20437434
[patent_doc_number] => 12508255
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-30
[patent_title] => Methods and products for improving sperm quality
[patent_app_type] => utility
[patent_app_number] => 18/949880
[patent_app_country] => US
[patent_app_date] => 2024-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 18
[patent_no_of_words] => 15248
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18949880
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/949880 | Methods and products for improving sperm quality | Nov 14, 2024 | Issued |
Array
(
[id] => 19613025
[patent_doc_number] => 20240398705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => OPHTHALMIC COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/784718
[patent_app_country] => US
[patent_app_date] => 2024-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49410
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18784718
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/784718 | OPHTHALMIC COMPOSITION | Jul 24, 2024 | Pending |
Array
(
[id] => 19613025
[patent_doc_number] => 20240398705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => OPHTHALMIC COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/784718
[patent_app_country] => US
[patent_app_date] => 2024-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49410
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18784718
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/784718 | OPHTHALMIC COMPOSITION | Jul 24, 2024 | Pending |
Array
(
[id] => 19613025
[patent_doc_number] => 20240398705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => OPHTHALMIC COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/784718
[patent_app_country] => US
[patent_app_date] => 2024-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49410
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18784718
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/784718 | OPHTHALMIC COMPOSITION | Jul 24, 2024 | Pending |
Array
(
[id] => 19526514
[patent_doc_number] => 20240350416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING ENZALUTAMIDE
[patent_app_type] => utility
[patent_app_number] => 18/762066
[patent_app_country] => US
[patent_app_date] => 2024-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3999
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18762066
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/762066 | PHARMACEUTICAL COMPOSITION COMPRISING ENZALUTAMIDE | Jul 1, 2024 | Pending |
Array
(
[id] => 19554844
[patent_doc_number] => 20240366636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => ORAL CANNABINOID PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING INFLAMMATORY GASTROINTESTINAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/759282
[patent_app_country] => US
[patent_app_date] => 2024-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26161
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18759282
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/759282 | ORAL CANNABINOID PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING INFLAMMATORY GASTROINTESTINAL DISORDERS | Jun 27, 2024 | Pending |
Array
(
[id] => 19526598
[patent_doc_number] => 20240350500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING METASTATIC CANCER
[patent_app_type] => utility
[patent_app_number] => 18/751006
[patent_app_country] => US
[patent_app_date] => 2024-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23528
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18751006
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/751006 | PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING METASTATIC CANCER | Jun 20, 2024 | Abandoned |
Array
(
[id] => 19554726
[patent_doc_number] => 20240366518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/735095
[patent_app_country] => US
[patent_app_date] => 2024-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70656
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18735095
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/735095 | COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF | Jun 4, 2024 | Pending |
Array
(
[id] => 19730096
[patent_doc_number] => 12208082
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-01-28
[patent_title] => Method of treating middle east respiratory syndrome (MERS)
[patent_app_type] => utility
[patent_app_number] => 18/654709
[patent_app_country] => US
[patent_app_date] => 2024-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 5624
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18654709
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/654709 | Method of treating middle east respiratory syndrome (MERS) | May 2, 2024 | Issued |
Array
(
[id] => 19359266
[patent_doc_number] => 20240261300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => METHODS OF TREATING CONGENITAL ADRENAL HYPERPLASIA
[patent_app_type] => utility
[patent_app_number] => 18/438060
[patent_app_country] => US
[patent_app_date] => 2024-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19942
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18438060
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/438060 | METHODS OF TREATING CONGENITAL ADRENAL HYPERPLASIA | Feb 8, 2024 | Pending |
Array
(
[id] => 19170791
[patent_doc_number] => 20240156765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => METHODS OF NEUROPROTECTION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/420262
[patent_app_country] => US
[patent_app_date] => 2024-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29925
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18420262
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/420262 | METHODS OF NEUROPROTECTION AND USES THEREOF | Jan 22, 2024 | Pending |
Array
(
[id] => 19521063
[patent_doc_number] => 12122770
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-10-22
[patent_title] => 2-(benzo[d]oxazol-2-yl)-n'-(nicotinoyloxy)acetimidamide as an antimicrobial compound
[patent_app_type] => utility
[patent_app_number] => 18/397098
[patent_app_country] => US
[patent_app_date] => 2023-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4043
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18397098
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/397098 | 2-(benzo[d]oxazol-2-yl)-n'-(nicotinoyloxy)acetimidamide as an antimicrobial compound | Dec 26, 2023 | Issued |
Array
(
[id] => 19226663
[patent_doc_number] => 12006296
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-06-11
[patent_title] => 5-(4-methoxyphenyl)-1-hexyl-2-(4-nitrophenyl)-4-phenyl-1H-imidazoleas an antimicrobial compound
[patent_app_type] => utility
[patent_app_number] => 18/535770
[patent_app_country] => US
[patent_app_date] => 2023-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4260
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18535770
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/535770 | 5-(4-methoxyphenyl)-1-hexyl-2-(4-nitrophenyl)-4-phenyl-1H-imidazoleas an antimicrobial compound | Dec 10, 2023 | Issued |
Array
(
[id] => 19172372
[patent_doc_number] => 20240158346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => METHOD OF PREPARING IONIC FLUIDS
[patent_app_type] => utility
[patent_app_number] => 18/519337
[patent_app_country] => US
[patent_app_date] => 2023-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5732
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18519337
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/519337 | Method of preparing ionic fluids | Nov 26, 2023 | Issued |
Array
(
[id] => 19297489
[patent_doc_number] => 20240226054
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-07-11
[patent_title] => AGENTS AND METHODS FOR PREVENTING AND TREATING SKELETAL MUSCLE DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/383256
[patent_app_country] => US
[patent_app_date] => 2023-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11570
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18383256
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/383256 | AGENTS AND METHODS FOR PREVENTING AND TREATING SKELETAL MUSCLE DISEASES | Oct 23, 2023 | Pending |
Array
(
[id] => 19297489
[patent_doc_number] => 20240226054
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-07-11
[patent_title] => AGENTS AND METHODS FOR PREVENTING AND TREATING SKELETAL MUSCLE DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/383256
[patent_app_country] => US
[patent_app_date] => 2023-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11570
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18383256
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/383256 | AGENTS AND METHODS FOR PREVENTING AND TREATING SKELETAL MUSCLE DISEASES | Oct 23, 2023 | Pending |
Array
(
[id] => 19297489
[patent_doc_number] => 20240226054
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-07-11
[patent_title] => AGENTS AND METHODS FOR PREVENTING AND TREATING SKELETAL MUSCLE DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/383256
[patent_app_country] => US
[patent_app_date] => 2023-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11570
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18383256
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/383256 | AGENTS AND METHODS FOR PREVENTING AND TREATING SKELETAL MUSCLE DISEASES | Oct 22, 2023 | Pending |
Array
(
[id] => 19297489
[patent_doc_number] => 20240226054
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-07-11
[patent_title] => AGENTS AND METHODS FOR PREVENTING AND TREATING SKELETAL MUSCLE DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/383256
[patent_app_country] => US
[patent_app_date] => 2023-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11570
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18383256
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/383256 | AGENTS AND METHODS FOR PREVENTING AND TREATING SKELETAL MUSCLE DISEASES | Oct 22, 2023 | Pending |